Emerson Arcoverde
Psychiatrist and faculty member in the Department of Clinical Medicine at the Federal University of Rio Grande do Norte (UFRN)
Data updated
Research Footprint
Emerson Arcoverde appears in 5 tracked papers (2018–2025), most studied alongside DMT, Ayahuasca and Psilocybin, across Depressive Disorders, Treatment-Resistant Depression (TRD) and Anxiety Disorders.
Most-cited paper: Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial (814 citations).
Frequent co-authors: Fernanda Palhano-Fontes, Draulio Araújo and Nathalia Galvão-Coelho.
Background & Research
Emerson Arcoverde Nunes is a Brazilian psychiatrist associated with the Federal University of Rio Grande do Norte and the Onofre Lopes University Hospital (HUOL/UFRN). His work has included psychopharmacology, mood disorders, psychosis, and translational clinical research, including major contributions to ayahuasca and DMT trials in depression. He has also been listed as a clinical/teaching psychiatrist in UFRN-linked academic records.
Key Impact
He is a clinician-researcher on randomized and phase I/II psychedelic studies of ayahuasca and inhaled/vaporized DMT for treatment-resistant depression.
Collaboration Network
19 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Emerson Arcoverde is associated with.